PLx Pharma (NASDAQ:PLXP) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.21) by 19.05 percent. This is a 32.43 percent increase over losses of $(0.37) per share from the same period last year.
Dogecoin Community Helps Ukraine, Funds Flowing In
The community behind Dogecoin (CRYPTO: DOGE) — the world's leading memecoin — came together to help Ukraine after the country was invaded by its neighbor Russia.